mitochondrial glutathione s transferase S-transferase pellemista Triple Liposomal Glutathione Drink:Combo ELASTEN + Triple Liposome Glutathione Frontiers | Microbiota, natural

mitochondrial glutathione s transferase S-transferase pellemista Triple Liposomal Glutathione Drink:Combo ELASTEN + Triple Liposome Glutathione Frontiers | Microbiota, natural

Frontiers | Microbiota, natural products, and human health: exploring interactions for therapeutic insights

Disclosures: Mary Ellen Mackesy-Amiti: Nothing to Disclose, Alexander Gutfraind: Nothing to Disclose, Eric Tatara: Nothing to Disclose, Nicholson Collier: Nothing to Disclose, Scott Cotler: Nothing to Disclose, Kimberly Page: Nothing to Disclose, Jonathan Ozik: Nothing to Disclose, Basmattee Boodram: Nothing to Disclose, Marian Major: Nothing to Disclose, Harel Dahari: Nothing to Disclose 556 BEMNIFOSBUVIR POSES HIGH BARRIER FOR RESISTANCE IN BOTH PRECLINICAL AND PHASE 1B MONOTHERAPY STUDIES Qi Huang 1 Dawei Cai 1 Shannan Lynch 1 Keith Pietropaolo 1 Xiao-Jian Zhou 1 Nancy Agrawal 1 Jean-Pierre Sommadossi 2 , 1 Atea Pharmaceuticals, Inc., 2 Atea Pharmaceuticals, Inc Background: Bemnifosbuvir (BEM), an oral prodrug of a guanosine analog, has potent pan-genotypic, best-in-class in vitro and clinical antiviral activities against all HCV genotypes tested

pellemista

Triple Liposomal Glutathione Drink:Combo ELASTEN + Triple Liposome Glutathione

⚠ Stacks are discussed for experimental design only